NEW YORK (GenomeWeb) – Alere confirmed today that it is in full compliance with its merger agreement with Abbott Laboratories following a report Wednesday that Abbott was exercising its contractual right to audit the books and records of Alere, and that Abbott had received a partial response from Alere.

"We are confident that the transaction will be completed in accordance with its terms," said Jackie Lustig, senior director of corporate communications at Alere. "That's all we can say at this time."

Abbott officials did not return calls to GenomeWeb seeking comment.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.

Jan
30
Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.

Feb
21
Sponsored by
L7 Informatics

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.